Archive for December, 2016

18 public hospitals stop drug mark-up in Jiangmen

December 16th, 2016 | by

The pilot implementation plan of the price adjustment of medical services in public hospitals in Jiangmen came recently into effect. According to the implementation plan, the 15% of drug mark-up is cancelled in 18 public hospitals in Jiangmen, to realize the drug sale without added profit (excluding traditional Chinese medicine decoction pieces), i.e. the actual purchase price is the sale price. Except the adjustment of the drug price, the prices of more than 90 examination and therapy items and around 2145 inspection items are reduced by 5%-12%. At the same time, the prices of five kinds of medical services which reflect the technical service values are increased, including examination fee, nursing care fee, bed fee, operation fee and therapy fee. (Source: Guangzhou Daily)


来源:广州日报 2016-12-09

核心提示:《江门市城市公立医院医疗服务价格调整实施方案(试行)》近日正式实施。按照该实施方案,江门18所公立医院自此取消原不超过15%的药品加成率,实现药品零差率销售(中药饮片除外),即以实际购进价作为销售价格。除了药品价格的调整,90多项大型医用设备检查治疗项目和约2145项的检验项目收费标准分别下调5%- 12%。与此同时,5类体现医务人员技术劳务价值的医疗服务价格有所提高,其中包括诊查费、护理费、床位费、手术费和治疗费。

Adjusting the price management mode of low-price drugs in Hunan

December 16th, 2016 | by

Hunan Development and Reform Commission recently published an announcement concerning drug prices. The announcement clarifies related policies about drug prices in Hunan medical institutions. According to the announcement, since the publication date of the announcement, sales without added profit should be implemented basing on the actual purchase price, when public medical institutions sell drugs (including secondary vaccine, excluding traditional Chinese medicine decoction pieces). For the sale of traditional Chinese medicine decoction pieces in public medical institutions, the added profit should not exceed 30 % on the basis of the cost price with tax (the wholesale price). The added profit of non-public medical institutions and social retail pharmacies can be formulated by institutions and pharmacies themselves. Drug prices should be shown to the public. (Source: Chinese Medicine News)


来源:中国医药报 2016-12-08


CFDA ferrets out Illegal ingredients – five pharmaceutical manufacturers stop the production

December 16th, 2016 | by

In the evening of 7th December, CFDA published the No.159 casual inspection announcement in 2016. In the national drug casual inspection, drugs in six batches from five manufacturers were ferreted out to contain abietic acid or Scarlet 808. The Food and Drug Administrations of Jilin, Qinghai and Tibet Autonomous Region have already taken the product control actions to seal up, distrain, stop selling and recall the ferreted drugs. Withal CFDA asked FDAs of Jilin, Qinghai and Tibet Autonomous Region to immediately instruct the manufacturers to stop related productions and investigate the reasons thoroughly. The production should not be recovered until the reasons are clear and the rectifications are done. (Source: Chinamsr)


来源:中国医药联盟 2016-12-08